Hepatitis virus core proteins as vaccine platforms and methods of use thereof
CA 2534060 C · Owner: Vlp Biotech, Inc. · Inventors: Billaud, Jean-Noel; Milich, David R.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to hepatitis virus core proteins and nucleic acids. In particular, the present invention provides compositions and methods comprising recombinant hepatitis virus core proteins or nucleic acids for use in vaccine formulations.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 19, 2004 and granted June 12, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended July 19, 2024.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 19, 2026.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.